123 related articles for article (PubMed ID: 32878767)
1. Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model.
Lu J; Chen A; Ma X; Shang X; Zhang Y; Guo Y; Liu M; Wang X
Drug Metab Dispos; 2020 Nov; 48(11):1129-1136. PubMed ID: 32878767
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a Novel
Sun D; Lu J; Zhang Y; Liu J; Liu Z; Yao B; Guo Y; Wang X
Drug Metab Dispos; 2021 Aug; 49(8):638-647. PubMed ID: 34074728
[TBL] [Abstract][Full Text] [Related]
3. CRISPR knockout rat cytochrome P450 3A1/2 model for advancing drug metabolism and pharmacokinetics research.
Lu J; Shao Y; Qin X; Liu D; Chen A; Li D; Liu M; Wang X
Sci Rep; 2017 Feb; 7():42922. PubMed ID: 28218310
[TBL] [Abstract][Full Text] [Related]
4. Characterization of novel cytochrome P450 2E1 knockout rat model generated by CRISPR/Cas9.
Wang X; Tang Y; Lu J; Shao Y; Qin X; Li Y; Wang L; Li D; Liu M
Biochem Pharmacol; 2016 Apr; 105():80-90. PubMed ID: 26947455
[TBL] [Abstract][Full Text] [Related]
5. Development and Characterization of MDR1 (
Liang C; Zhao J; Lu J; Zhang Y; Ma X; Shang X; Li Y; Ma X; Liu M; Wang X
Drug Metab Dispos; 2019 Feb; 47(2):71-79. PubMed ID: 30478157
[TBL] [Abstract][Full Text] [Related]
6. CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance.
Zeldin DC; Foley J; Ma J; Boyle JE; Pascual JM; Moomaw CR; Tomer KB; Steenbergen C; Wu S
Mol Pharmacol; 1996 Nov; 50(5):1111-7. PubMed ID: 8913342
[TBL] [Abstract][Full Text] [Related]
7. Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases.
Aiba I; Yamasaki T; Shinki T; Izumi S; Yamamoto K; Yamada S; Terato H; Ide H; Ohyama Y
Steroids; 2006 Oct; 71(10):849-56. PubMed ID: 16842832
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole.
Matsumoto S; Hirama T; Matsubara T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2002 Nov; 30(11):1240-5. PubMed ID: 12386130
[TBL] [Abstract][Full Text] [Related]
9. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance.
Zeldin DC; Foley J; Goldsworthy SM; Cook ME; Boyle JE; Ma J; Moomaw CR; Tomer KB; Steenbergen C; Wu S
Mol Pharmacol; 1997 Jun; 51(6):931-43. PubMed ID: 9187259
[TBL] [Abstract][Full Text] [Related]
10. Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene.
Liu J; Shang X; Huang S; Xu Y; Lu J; Zhang Y; Liu Z; Wang X
Mol Pharmacol; 2021 Nov; 100(5):480-490. PubMed ID: 34503976
[TBL] [Abstract][Full Text] [Related]
11. CYP2J deficiency leads to cardiac injury and presents dual regulatory effects on cardiac function in rats.
Zhang Y; Lu J; Huang S; Zhang Y; Liu J; Xu Y; Yao B; Wang X
Toxicol Appl Pharmacol; 2023 Aug; 473():116610. PubMed ID: 37385478
[TBL] [Abstract][Full Text] [Related]
12. Design and Construction of Carboxylesterase 2c Gene Knockout Rats by CRISPR/Cas9.
Liu J; Shang X; Yao B; Zhang Y; Huang S; Guo Y; Wang X
Curr Drug Metab; 2023; 24(3):190-199. PubMed ID: 36694315
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome
Uno Y; Murayama N; Ijiri M; Kawaguchi H; Yamato O; Shiraishi M; Asano A; Teraoka H; Mizukawa H; Nakayama SMM; Ikenaka Y; Ishizuka M; Yamazaki H
Drug Metab Dispos; 2022 Nov; 50(11):1434-1441. PubMed ID: 35701183
[TBL] [Abstract][Full Text] [Related]
14. Marmoset cytochrome P450 2J2 mainly expressed in small intestines and livers effectively metabolizes human P450 2J2 probe substrates, astemizole and terfenadine.
Uehara S; Uno Y; Inoue T; Okamoto E; Sasaki E; Yamazaki H
Xenobiotica; 2016 Nov; 46(11):977-85. PubMed ID: 26899760
[TBL] [Abstract][Full Text] [Related]
15. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.
Wu S; Chen W; Murphy E; Gabel S; Tomer KB; Foley J; Steenbergen C; Falck JR; Moomaw CR; Zeldin DC
J Biol Chem; 1997 May; 272(19):12551-9. PubMed ID: 9139707
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the cytochrome P450 CYP2J4: expression in rat small intestine and role in retinoic acid biotransformation from retinal.
Zhang QY; Raner G; Ding X; Dunbar D; Coon MJ; Kaminsky LS
Arch Biochem Biophys; 1998 May; 353(2):257-64. PubMed ID: 9606960
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of cytochrome P450 1A1 CRISPR/Cas9 Knockout Bovine Foetal Hepatocyte Cell Line (BFH12).
Iori S; D'Onofrio C; Laham-Karam N; Mushimiyimana I; Lucatello L; Lopparelli RM; Gelain ME; Capolongo F; Pauletto M; Dacasto M; Giantin M
Cell Biol Toxicol; 2024 Mar; 40(1):18. PubMed ID: 38528259
[TBL] [Abstract][Full Text] [Related]
19. Glutamate affects the production of epoxyeicosanoids within the brain: The up-regulation of brain CYP2J through the MAPK-CREB signaling pathway.
Liu M; Zhu Q; Wu J; Yu X; Hu M; Xie X; Yang Z; Yang J; Feng YQ; Yue J
Toxicology; 2017 Apr; 381():31-38. PubMed ID: 28237619
[TBL] [Abstract][Full Text] [Related]
20. Construction of humanized CYP1A2 rats using CRISPR/Cas9 to promote drug metabolism and pharmacokinetic research.
Liu J; Lu J; Yao B; Zhang Y; Huang S; Chen X; Shen Y; Wang X
Drug Metab Dispos; 2023 Oct; ():. PubMed ID: 37884392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]